Dan Goldstein Insider Trading $HAE HAEMONETICS CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Dan Goldstein.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Dan Goldstein. Dan Goldstein is Chief Accounting Officer in HAEMONETICS CORP ($HAE) and VP, Corporate Controller in HAEMONETICS CORP ($HAE).

Dan Goldstein in HAEMONETICS CORP

Trading Symbol: HAE
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Dan Goldstein: VP, Corporate Controller, Chief Accounting Officer
Holdings: 1,749 shares
Current Value: $64,975
Latest Transaction: Oct 28 2020
$HAE Market Capitalization: $1.91B
$HAE Previous Close: $37.15

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Dan Goldstein in HAEMONETICS CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 28 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	106.00	100	10,600	1,749	1.8 K to 1.7 K (-5.41 %)
Jun 16 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	91.53	3,040	278,251	1,849	4.9 K to 1.8 K (-62.18 %)
Jun 16 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	87.71	1,282	112,444	4,889	6.2 K to 4.9 K (-20.77 %)
Jun 16 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	87.16	92	8,019	6,171	6.3 K to 6.2 K (-1.47 %)
Jun 16 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	82.29	42	3,456	6,263	6.3 K to 6.3 K (-0.67 %)
Jun 16 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Grant	A	0.00	4,322	0	6,305	2 K to 6.3 K (+217.95 %)
Jun 10 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	41.64	1,106	46,054	1,107
Jun 10 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	97.19	187	18,175	1,983	2.2 K to 2 K (-8.62 %)
Jun 10 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	99.09	1,106	109,594	2,170	3.3 K to 2.2 K (-33.76 %)
Jun 10 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	41.64	1,106	46,054	3,276	2.2 K to 3.3 K (+50.97 %)
Jun 10 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	97.03	83	8,053	2,170	2.3 K to 2.2 K (-3.68 %)
May 19 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	A	103.37	1,841	190,304	1,841
May 19 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Grant	A	0.00	544	0	2,253	1.7 K to 2.3 K (+31.83 %)
May 19 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	101.72	101	10,274	1,709	1.8 K to 1.7 K (-5.58 %)
May 19 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	100.44	42	4,218	1,810	1.9 K to 1.8 K (-2.27 %)
Apr 08 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	34.42	2,607	89,733	0
Apr 08 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	97.12	399	38,751	1,852	2.3 K to 1.9 K (-17.73 %)
Apr 08 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	103.91	201	20,886	2,251	2.5 K to 2.3 K (-8.20 %)
Apr 08 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	101.62	2,607	264,923	2,452	5.1 K to 2.5 K (-51.53 %)
Apr 08 2020	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	34.42	2,607	89,733	5,059	2.5 K to 5.1 K (+106.32 %)
Oct 29 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	34.21	1,456	49,810	1,457
Oct 29 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	122.69	237	29,078	2,452	2.7 K to 2.5 K (-8.81 %)
Oct 29 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	120.33	100	12,033	2,689	2.8 K to 2.7 K (-3.59 %)
Oct 29 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	120.32	1,456	175,186	2,789	4.2 K to 2.8 K (-34.30 %)
Oct 29 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	34.21	1,456	49,810	4,245	2.8 K to 4.2 K (+52.21 %)
Aug 12 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	93.52	475	44,422	1,428
Aug 12 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	133.23	475	63,284	2,789	3.3 K to 2.8 K (-14.55 %)
Aug 12 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	93.52	475	44,422	3,264	2.8 K to 3.3 K (+17.03 %)
Jun 17 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	110.58	94	10,395	2,789	2.9 K to 2.8 K (-3.26 %)
Jun 13 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	109.37	39	4,265	2,883	2.9 K to 2.9 K (-1.33 %)
Jun 12 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	104.38	192	20,041	2,922	3.1 K to 2.9 K (-6.17 %)
Jun 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	41.64	1,107	46,095	2,213
Jun 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	103.38	78	8,064	3,114	3.2 K to 3.1 K (-2.44 %)
Jun 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	103.25	1,107	114,298	3,192	4.3 K to 3.2 K (-25.75 %)
Jun 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	41.64	1,107	46,095	4,299	3.2 K to 4.3 K (+34.68 %)
May 16 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	A	98.03	2,003	196,344	2,003
May 16 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Grant	A	0.00	573	0	3,192	2.6 K to 3.2 K (+21.88 %)
May 16 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	A	98.03	2,003	196,344	2,003
May 16 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Grant	A	0.00	573	0	3,192	2.6 K to 3.2 K (+21.88 %)
Apr 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	34.42	2,607	89,733	2,607
Apr 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	88.99	389	34,617	2,619	3 K to 2.6 K (-12.93 %)
Apr 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	88.31	210	18,545	3,008	3.2 K to 3 K (-6.53 %)
Apr 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	88.93	2,607	231,841	3,218	5.8 K to 3.2 K (-44.76 %)
Apr 10 2019	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	34.42	2,607	89,733	5,825	3.2 K to 5.8 K (+81.01 %)
Dec 12 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	34.21	1,457	49,844	2,913
Dec 12 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	102.91	1,693	174,227	3,218	4.9 K to 3.2 K (-34.47 %)
Dec 12 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	34.21	1,457	49,844	4,911	3.5 K to 4.9 K (+42.18 %)
Oct 30 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	101.69	102	10,372	3,454	3.6 K to 3.5 K (-2.87 %)
Jun 13 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	A	93.52	1,903	177,969	1,903
Jun 13 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Grant	A	0.00	534	0	3,556	3 K to 3.6 K (+17.67 %)
Jun 12 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	92.90	578	53,696	3,022	3.6 K to 3 K (-16.06 %)
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	41.64	1,106	46,054	3,320
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Option Exercise	M	34.42	2,607	89,733	5,214
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	92.73	81	7,511	3,600	3.7 K to 3.6 K (-2.20 %)
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	95.14	1,106	105,225	3,681	4.8 K to 3.7 K (-23.10 %)
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	95.14	2,607	248,030	4,787	7.4 K to 4.8 K (-35.26 %)
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	41.64	1,106	46,054	7,394	6.3 K to 7.4 K (+17.59 %)
Jun 08 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Buy	M	34.42	2,607	89,733	6,288	3.7 K to 6.3 K (+70.82 %)
Apr 10 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	72.19	210	15,160	3,681	3.9 K to 3.7 K (-5.40 %)
Apr 10 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	46.76	111	5,190	3,891	4 K to 3.9 K (-2.77 %)
Apr 10 2018	HAE	HAEMONETICS CORP	Goldstein Dan	VP, Corporate Contr ...	Sell	S	40.39	197	7,957	4,002	4.2 K to 4 K (-4.69 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Option Exercise	M	34.21	1,456	49,810	4,370
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Option Exercise	M	34.42	2,607	89,733	7,821
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Option Exercise	A	41.64	4,426	184,299	4,426
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Option Exercise	A	34.21	5,826	199,307	5,826
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.89	68	3,732	4,199	4.3 K to 4.2 K (-1.59 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.84	560	30,711	4,267	4.8 K to 4.3 K (-11.60 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.96	956	52,539	4,827	5.8 K to 4.8 K (-16.53 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.94	200	10,988	5,783	6 K to 5.8 K (-3.34 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.92	300	16,476	5,983	6.3 K to 6 K (-4.77 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Sell	S	54.95	2,607	143,242	6,283	8.9 K to 6.3 K (-29.33 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Buy	M	34.21	1,456	49,810	8,890	7.4 K to 8.9 K (+19.59 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Buy	M	34.42	2,607	89,733	7,434	4.8 K to 7.4 K (+54.01 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Grant	A	0.00	1,080	0	4,827	3.7 K to 4.8 K (+28.82 %)
Nov 15 2017	HAE	HAEMONETICS CORP	Goldstein Dan	Chief Accounting Of ...	Grant	A	0.00	1,350	0	3,747	2.4 K to 3.7 K (+56.32 %)

Page: 1